Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Stoter

Showing results (71-80 of 249) with videos related to

Pageof 25
Sort By:
The New England Journal of Medicine|October 18, 1990
Acute fatal leukoencephalopathy after interleukin-2 therapyC J Vecht, C Keohane, R S Menon, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1994
The importance of bleomycin in combination chemotherapy for good-prognosis germ cell carcinomaG Stoter, S B Kaye, P H de Mulder, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 15, 1987
Regulation of cytolytic activity in CD3- and CD3+ killer cell clones by monoclonal antibodies (anti-CD16, anti-CD2, anti-CD3) depends on subclass specificity of target cell IgG-FcRR J van de Griend, R L Bolhuis, G Stoter, et al.
Lancet (London, England)|June 28, 1997
Multidrug resistance protein in recurrent breast cancerK Nooter, G B de la Riviere, J Klijn, et al.
Biochemical and Biophysical Research Communications|March 18, 2000
A genome-wide screening in Saccharomyces cerevisiae for genes that confer resistance to the anticancer agent cisplatinH Burger, A Capello, P W Schenk, et al.
European Journal of Cancer (Oxford, England : 1990)|June 13, 1998
Expression of the multidrug resistance protein (MRP) in squamous cell carcinoma of the oesophagus and response to pre-operative chemotherapyK Nooter, T Kok, F T Bosman, et al.
Lancet (London, England)|July 25, 1992
Bioavailability of interleukin-2 after reconstitution with albuminC H Lamers, G Stoter, S H Goey, et al.
European Journal of Cancer & Clinical Oncology|April 1, 1988
Ifosfamide in advanced head and neck cancer. A phase II study of the Rotterdam Cooperative Head and Neck Cancer Study GroupJ Verweij, J Alexieva-Figusch, M F de Boer, et al.
The Netherlands Journal of Medicine|December 1, 1990
Mechanical ventilation in cancer patients. Analysis of clinical data and outcomeA Dees, J L Ligthart, W L van Putten, et al.
The Cancer Journal From Scientific American|February 11, 1998
Recombinant interleukin-2-based treatments for advanced melanoma: the experience of the European Organization for Research and Treatment of Cancer Melanoma Cooperative GroupU Keilholz, G Stoter, C J Punt, et al.
Pageof 25

Showing results (71-80 of 249) with videos related to

Sort By:
Pageof 25
The New England Journal of Medicine|October 18, 1990
Acute fatal leukoencephalopathy after interleukin-2 therapyC J Vecht, C Keohane, R S Menon, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1994
The importance of bleomycin in combination chemotherapy for good-prognosis germ cell carcinomaG Stoter, S B Kaye, P H de Mulder, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 15, 1987
Regulation of cytolytic activity in CD3- and CD3+ killer cell clones by monoclonal antibodies (anti-CD16, anti-CD2, anti-CD3) depends on subclass specificity of target cell IgG-FcRR J van de Griend, R L Bolhuis, G Stoter, et al.
Lancet (London, England)|June 28, 1997
Multidrug resistance protein in recurrent breast cancerK Nooter, G B de la Riviere, J Klijn, et al.
Biochemical and Biophysical Research Communications|March 18, 2000
A genome-wide screening in Saccharomyces cerevisiae for genes that confer resistance to the anticancer agent cisplatinH Burger, A Capello, P W Schenk, et al.
European Journal of Cancer (Oxford, England : 1990)|June 13, 1998
Expression of the multidrug resistance protein (MRP) in squamous cell carcinoma of the oesophagus and response to pre-operative chemotherapyK Nooter, T Kok, F T Bosman, et al.
Lancet (London, England)|July 25, 1992
Bioavailability of interleukin-2 after reconstitution with albuminC H Lamers, G Stoter, S H Goey, et al.
European Journal of Cancer & Clinical Oncology|April 1, 1988
Ifosfamide in advanced head and neck cancer. A phase II study of the Rotterdam Cooperative Head and Neck Cancer Study GroupJ Verweij, J Alexieva-Figusch, M F de Boer, et al.
The Netherlands Journal of Medicine|December 1, 1990
Mechanical ventilation in cancer patients. Analysis of clinical data and outcomeA Dees, J L Ligthart, W L van Putten, et al.
The Cancer Journal From Scientific American|February 11, 1998
Recombinant interleukin-2-based treatments for advanced melanoma: the experience of the European Organization for Research and Treatment of Cancer Melanoma Cooperative GroupU Keilholz, G Stoter, C J Punt, et al.
Pageof 25